journal article·2020-12Open access

Engineering ferrite nanoparticles with enhanced magnetic response for advanced biomedical applications

Y. Wang, Y. Miao, G. Li, M. Su, X. Chen, H. Zhang, Y. Zhang, W. Jiao, Y. He, J. Yi, X. Liu, H. Fan

Abstract

One of the most attractive features of magnetic ferrite nanoparticles (MFNPs) in biomedical application is that they can mediate external magnetic field to produce local magnetic field, magnetic thermal and magnetic force effects. These generated effects can later be utilized in the diagnosis and treatment of various diseases. The application performance is mainly determined by the nano-magnetism of MFNPs. Therefore, by modulating the magnetic properties, the improved magnetic resonance (MR) signals, magnetothermal, and magnetomechanical effects of the MFNPs can be achieved. In this review, we summarize the strategies used in the engineering of MFNPs to enhance MR imaging sensitivity and magnetic thermal conversion efficiencies. We will also discuss the detailed magnetoresponsive mechanism arising from the critical magnetic properties of MFNPs. Furthermore, we will highlight the recent progresses of the engineered MFNPs in biomedical applications, with emphasis in MR signal amplification, magnetothermal, and magnetomechanical response in biomedical applications.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Characterization and Applications of Magnetic Nanoparticles · Nanoparticle-Based Drug Delivery · Magnetic Properties and Synthesis of Ferrites

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (100+)

Show source-provided references
1. Iron oxide based nanoparticles for multimodal imaging and magnetoresponsive therapy10.1021/acs.chemrev.5b00112 ↗
2. Iron oxide nanoclusters for T1 magnetic resonance imaging of non-human primates10.1038/s41551-017-0116-7 ↗
3. Exchange-coupled magnetic nanoparticles for efficient heat induction10.1038/nnano.2011.95 ↗
4. Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging10.1038/nm1467 ↗
5. Multifunctional magnetic nanoparticles: design, synthesis, and biomedical applications10.1021/ar9000026 ↗
6. Magnetoferritin nanoparticles for targeting and visualizing tumour tissues10.1038/nnano.2012.90 ↗
7. Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging10.1016/j.addr.2009.11.002 ↗
8. Subnanometer local temperature probing and remotely controlled drug release based on azo-functionalized iron oxide nanoparticles10.1021/nl400188q ↗
9. In vitro characterization of movement, heating and visualization of magnetic nanoparticles for biomedical applications10.1088/0957-4484/16/8/041 ↗
10. Magnetofossils, the magnetization of sediments, and the evolution of magnetite biomineralization10.1146/annurev.ea.17.050189.001125 ↗
11. Clinical translation of nanomedicine10.1021/acs.chemrev.5b00116 ↗
12. Recent advances in magnetic nanoparticle-based multi-modal imaging10.1039/C4CS00345D ↗
13. Giant magnetic heat induction of magnesium-doped gamma-Fe2O3 superparamagnetic nanoparticles for completely killing tumors10.1002/adma.201704362 ↗
14. Small-scale soft-bodied robot with multimodal locomotion10.1038/nature25443 ↗
15. Remote control of ion channels and neurons through magnetic-field heating of nanoparticles10.1038/nnano.2010.125 ↗
16. Remote control of heterodimeric magnetic nanoswitch regulates the adhesion and differentiation of stem cells10.1021/jacs.8b03001 ↗
17. Recent advances in magnetic-nanomaterial-based mechanotransduction for cell fate regulation10.1002/adma.201705673 ↗
18. Size-dependent heating of magnetic iron oxide nanoparticles10.1021/acsnano.7b01762 ↗
19. Enhanced magnetic hyperthermia in iron oxide nano-octopods: size and anisotropy effects10.1021/acs.jpcc.6b01426 ↗
20. Nanoscale magnetism control via surface and exchange anisotropy for optimized ferrimagnetic hysteresis10.1021/nl301499u ↗
21. Biocompatible nanoclusters with high heating efficiency for systemically delivered magnetic hyperthermia10.1021/acsnano.8b06542 ↗
22. Designed synthesis of uniformly sized iron oxide nanoparticles for efficient magnetic resonance imaging contrast agents10.1039/C1CS15248C ↗
23. Anchoring group effects of surface ligands on magnetic properties of Fe304 nanoparticles: towards high performance MRI contrast agents10.1002/adma.201304744 ↗
24. Paramagnetic metal complexes as water proton relaxation agents for NMR imaging theory and design10.1021/cr00081a003 ↗
25. Ultrasmall ferrite nanoparticles synthesized via dynamic simultaneous thermal decomposition for high-performance and multifunctional T1 magnetic resonance imaging contrast agent10.1021/acsnano.6b07684 ↗
26. Engineering of inorganic nanoparticles as magnetic resonance imaging contrast agents10.1039/C7CS00316A ↗
27. Structure-relaxivity relationships of magnetic nanoparticles for magnetic resonance imaging
28. Composition-tunable ultrasmall manganese ferrite nanoparticles: insights into their in vivo T1 contrast efficacy10.7150/thno.31233 ↗
29. Organic phase syntheses of magnetic nanoparticles and their applications10.1021/acs.chemrev.5b00687 ↗
30. What nephrologists need to know about gadolinium10.1038/ncpneph0660 ↗
31. Gadolinium-based contrast agent accumulates in the brain even in subjects without severe renal dysfunction: evaluation of autopsy brain specimens with inductively coupled plasma mass spectroscopy10.1148/radiol.2015142690 ↗
32. Intracranial gadolinium deposition after contrast-enhanced MR imaging10.1148/radiol.15150025 ↗
33. Gadolinium deposition in human brain tissues after contrast-enhanced MR imaging in ddult patients without intracranial abnormalities10.1148/radiol.2017161595 ↗
34. Engineered iron-oxide-based nanoparticles as enhanced T1 contrast agents for efficient tumor imaging10.1021/nn305991e ↗
35. Composition tunable manganese ferrite nanoparticles for optimized T2 contrast ability10.1021/acs.chemmater.7b00035 ↗
36. Anisotropic shaped iron oxide nanostructures: controlled synthesis and proton relaxation shortening effects10.1021/acs.chemmater.5b00944 ↗
37. Octapod iron oxide nanoparticles as high-performance T2 contrast agents for magnetic resonance imaging10.1038/ncomms3266 ↗
38. Coating engineering of MnFe2O4 nanoparticles with superhigh T2 relaxivity and efficient cellular uptake for highly sensitive magnetic resonance imaging10.1002/admi.201300069 ↗
39. Highly sensitive diagnosis of small hepatocellular carcinoma using pH-responsive iron oxide nanocluster assemblies10.1021/jacs.8b04169 ↗
40. Artificial local magnetic field inhomogeneity enhances T2 relaxivity10.1038/ncomms15468 ↗
41. Nanoscale size effect of magnetic nanocrystals and their utilization for cancer diagnosis via magnetic resonance imaging10.1021/ja0422155 ↗
42. Functionalization and magnetic relaxation of ferrite nanoparticles for theranostics10.1109/TMAG.2018.2845132 ↗
43. Size-dependent MR relaxivities of magnetic nanoparticles10.1016/j.jmmm.2016.11.021 ↗
44. Sensitive contrast-enhanced magnetic reso42nance imaging of orthotopic and metastatic hepatic tumors by ultralow doses of zinc ferrite octapods10.1021/acs.chemmater.8b04760 ↗
45. Tumor microenvironment-triggered aggregation of antiphagocytosis 99mTc-labeled Fe3O4 nanoprobes for enhanced tumor imaging in vivo10.1002/adma.201701095 ↗
46. Large-scale synthesis of uniform and extremely small-sized iron oxide nanoparticles for high-resolution T1 magnetic resonance imaging contrast agents10.1021/ja203340u ↗
47. A bioinspired nanoprobe with multilevel responsive T1-weighted MR signal-amplification illuminates ultrasmall metastases10.1002/adma.201906799 ↗
48. Dotted core-shell nanoparticles for T1-weighted MRI of tumors10.1002/adma.201803163 ↗
49. Ultrathin iron oxide nanowhiskers as positive contrast agents for magnetic resonance imaging10.1002/adfm.201403436 ↗
50. Surface and interfacial engineering of iron oxide nanoplates for highly efficient magnetic resonance angiography10.1021/nn507193f ↗
51. Self-confirming "AND" logic nanoparticles for fault-free MRI10.1021/ja104503g ↗
52. Distance-dependent magnetic resonance tuning as a versatile MRI sensing platform for biological targets10.1038/nmat4846 ↗
53. A synergistically enhanced T1-T2 dual-modal contrast agent10.1002/adma.201203169 ↗
54. Interplay between longitudinal and transverse contrasts in Fe3O4 nanoplates with (111) exposed surfaces10.1021/nn5038652 ↗
55. Exerting enhanced permeability and retention effect driven delivery by ultrafine iron oxide nanoparticles with T1-T2 switchable magnetic resonance imaging contrast10.1021/acsnano.7b00038 ↗
56. Dynamically reversible iron oxide nanoparticle assemblies for targeted amplification of T1-weighted magnetic resonance imaging of tumors10.1021/acs.nanolett.8b04411 ↗
57. Time-dependent T1-T2 switchable magnetic resonance imaging realized by c(RGDyK) modified ultrasmall Fe3O4 nanoprobes10.1002/adfm.201802281 ↗
58. Light-addressable nanoclusters of ultrasmall iron oxide nanoparticles for enhanced and dynamic magnetic resonance imaging of arthritis10.1002/advs.201901800 ↗
59. Two-way magnetic resonance tuning and enhanced subtraction imaging for non-invasive and quantitative biological imaging10.1038/s41565-020-0678-5 ↗
60. The dynamics of magnetic nanoparticles exposed to non-heating alternating magnetic field in biochemical applications: theoretical study10.1007/s11051-017-3753-6 ↗
61. Programmable ROS-mediated cancer therapy via magneto-inductions10.1002/advs.201902933 ↗
62. Single-cell mechanogenetics using monovalent magnetoplasmonic nanoparticles10.1038/nprot.2017.071 ↗
63. Towards nanomedicines of the future: remote magneto-mechanical actuation of nanomedicines by alternating magnetic fields10.1016/j.jconrel.2015.09.038 ↗
64. Magnetically tuning tether mobility of integrin ligand regulates ddhesion, spreading, and differentiation of stem cells10.1021/acs.nanolett.6b04958 ↗
65. Remote manipulation of ligand nano-oscillations regulates adhesion and polarization of macrophages in vivo10.1021/acs.nanolett.7b03405 ↗
66. Elongated nanoparticle aggregates in cancer cells for mechanical destruction with low frequency rotating magnetic field10.7150/thno.18352 ↗
67. Remote control of mechanical forces via mitochondrial-targeted magnetic nanospinners for efficient cancer treatment
68. Dynamic magnetic fields remote-control apoptosis via nanoparticle rotation10.1021/nn406302j ↗
69. Remote actuation of apoptosis in liver cancer cells via magneto-mechanical Modulation of iron oxide nanoparticles10.3390/cancers11121873 ↗
70. Magneto-actuated cell apoptosis by biaxial pulsed magnetic field10.1038/s41598-017-11279-w ↗
71. Magnetic forces enable controlled drug delivery by disrupting endothelial cell-cell junctions10.1038/ncomms15594 ↗
72. Use of oppositely polarized external magnets toimprove the accumulation and penetration of magnetic nanocarriers into solid tumors10.1021/acsnano.9b05660 ↗
73. Multifunctional biohybrid magnetite microrobots for imaging-guided therapy10.1126/scirobotics.aaq1155 ↗
74. Magnetic drug targeting: preclinical in vivo studies, mathematical modeling, and extrapolation to humans10.1021/acs.nanolett.6b02261 ↗
75. Shape-programmable magnetic soft matter10.1073/pnas.1608193113 ↗
76. Micronanorobots for biomedicine delivery, surgery, sensing, and detoxification10.1126/scirobotics.aam6431 ↗
77. A swarm of slippery micropropellers penetrates the vitreous body of the eye10.1126/sciadv.aat4388 ↗
78. Nanomagnetic encoding of shape-morphing micromachines10.1038/s41586-019-1713-2 ↗
79. Super-soft and super-elastic DNA robot with magnetically driven navigational locomotion for cell delivery in confined space10.1002/anie.201913549 ↗
80. Recent advances of magneto-thermal capabilities of nanoparticles: from design principles to biomedical applications10.1016/j.nantod.2017.02.006 ↗
81. Inductive thermal effect of ferrite magnetic nanoparticles10.3390/ma12193208 ↗
82. Size-sorted anionic iron oxide nanomagnets as colloidal mediators for magnetic hyperthermia10.1021/ja067457e ↗
83. Applications of magnetic nanoparticles in biomedicine10.1088/0022-3727/36/13/201 ↗
84. Suitability of commercial colloids for magnetic hyperthermia10.1016/j.jmmm.2009.02.075 ↗
85. Magnetic fluid hyperthermia: advances, challenges, and opportunity10.3109/02656736.2013.837200 ↗
86. Comprehensive understanding of magnetic hyperthermia for improving antitumor therapeutic efficacy10.7150/thno.40805 ↗
87. Specific loss power measurements by calorimetric and thermal methods on gamma-Fe2O3 nanoparticles for magnetic hyperthermia10.1016/j.jmmm.2018.10.107 ↗
88. Accuracy of available methods for quantifying the heat power generation of nanoparticles for magnetic hyperthermia10.3109/02656736.2013.826825 ↗
89. Magnetic nanoparticles based cancer therapy: current status and applications10.1007/s11427-017-9271-1 ↗
90. Morbidity and quality of life during thermotherapy using magnetic nanoparticles in locally recurrent prostate cancer: results of a prospective phase I trial10.1080/02656730601175479 ↗
91. Heating magnetic fluid with alternating magnetic field10.1016/S0304-8853(02)00706-0 ↗
92. Outstanding heat loss via nano-octahedra above 20 nm in size: from wustite-rich nanoparticles to magnetite single-crystals10.1039/C9NR04970C ↗
93. Magnetic vortex nanorings: a new class of hyperthermia agent for highly efficient in vivo regression of tumors10.1002/adma.201405036 ↗
94. Critical enhancements of MRI contrast and hyperthermic effects by dopant-controlled magnetic nanoparticles10.1002/anie.200805149 ↗
95. Optimization of surface coating on Fe3O4 nanoparticles for high performance magnetic hyperthermia agents10.1039/c2jm30472d ↗
96. Magnetic nanoparticle-loaded polymer nanospheres as magnetic hyperthermia agents10.1039/C3TB21146K ↗
97. Fe3O4-Pd Janus nanoparticles with amplified dual-mode hyperthermia and enhanced ROS generation for breast cancer treatment10.1039/C9NH00233B ↗
98. Graphene oxide-grafted magnetic nanorings mediated magnetothermodynamic therapy favoring reactive oxygen species-related immune response for enhanced antitumor efficacy10.1021/acsnano.9b08320 ↗
99. Chitosan magnetic nanoparticles for drug delivery systems10.1080/07388551.2016.1185389 ↗
100. Magnetic nanomaterials for hyperthermia-based therapy and controlled drug delivery10.1016/j.addr.2011.03.008 ↗